The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial

NCT00375388 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Metformin on top of intensive insulin therapy

Sponsor

Bethesda General Hospital, Hoogeveen

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]